| For: | Liu XH, Bai CG, Xie Q, Feng F, Xu ZY, Ma DL. Prognostic value of KIT mutation in gastrointestinal stromal tumors. World J Gastroenterol 2005; 11(25): 3948-3952 [PMID: 15991300 DOI: 10.3748/wjg.v11.i25.3948] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i25/3948.htm |
| Number | Citing Articles |
| 1 |
Antonio Chiappa, Andrew P Zbar, Michael Innis, Stuart Garriques, Emilio Bertani, Roberto Biffi, Giancarlo Pruneri, Felipe Luzzato, Paolo Della Vigna, Cristina Trovato, Bruno Andreoni. Prognostic factors affecting survival after surgical resection of gastrointestinal stromal tumours: a two-unit experience over 10 years. World Journal of Surgical Oncology 2006; 4(1) doi: 10.1186/1477-7819-4-73
|
| 2 |
R. S. Meara, J. Cangiarella, A. Simsir, D. Horton, I. Eltoum, D. C. Chhieng. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl‐2, Ki‐67 and p53. Cytopathology 2007; 18(5) doi: 10.1111/j.1365-2303.2007.00505.x
|
| 3 |
Jason S. Gold, Sanne M. van der Zwan, Mithat Gönen, Robert G. Maki, Samuel Singer, Murray F. Brennan, Cristina R. Antonescu, Ronald P. DeMatteo. Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors. Annals of Surgical Oncology 2007; 14(1) doi: 10.1245/s10434-006-9177-7
|
| 4 |
Christopher L. Corless, Christine M. Barnett, Michael C. Heinrich. Gastrointestinal stromal tumours: origin and molecular oncology. Nature Reviews Cancer 2011; 11(12) doi: 10.1038/nrc3143
|
| 5 |
Chun-Meng Wang, Kai Huang, Ye Zhou, Chun-Yan Du, Yan-Wei Ye, Hong Fu, Xiao-Yan Zhou, Ying-Qiang Shi. Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors. Journal of Cancer Research and Clinical Oncology 2010; 136(7) doi: 10.1007/s00432-009-0753-7
|
| 6 |
Allan D. Spigelman, Janindra Warusavitarne. Molecular Oncology. 2013; doi: 10.1017/CBO9781139046947.047
|
| 7 |
Christopher L. Corless, Michael C. Heinrich. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annual Review of Pathology: Mechanisms of Disease 2008; 3(1) doi: 10.1146/annurev.pathmechdis.3.121806.151538
|
| 8 |
Naoki Tanimine, Kazuaki Tanabe, Takahisa Suzuki, Noriaki Tokumoto, Hideki Ohdan. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-43
|
| 9 |
Klaudia Nowak, Kim Formenti, Jingyang Huang, Gilbert Bigras, Quincy Chu, Benjamin A. Adam, Iyare Izevbaye. Risk stratification of gastrointestinal stromal tumors by Nanostring gene expression profiling. Journal of Cancer Research and Clinical Oncology 2022; 148(6) doi: 10.1007/s00432-022-03924-3
|
| 10 |
R. L. Jones. Practical Aspects of Risk Assessment in Gastrointestinal Stromal Tumors. Journal of Gastrointestinal Cancer 2014; 45(3) doi: 10.1007/s12029-014-9615-x
|
| 11 |
Ronald P. DeMatteo, Jason S. Gold, Lisa Saran, Mithat Gönen, Kui Hin Liau, Robert G. Maki, Samuel Singer, Peter Besmer, Murray F. Brennan, Cristina R. Antonescu. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008; 112(3) doi: 10.1002/cncr.23199
|
| 12 |
Christopher L Corless. Gastrointestinal stromal tumors: what do we know now?. Modern Pathology 2014; 27 doi: 10.1038/modpathol.2013.173
|
| 13 |
Jennifer M. Racz, Savtaj S. Brar, Michelle C. Cleghorn, M. Carolina Jimenez, Arash Azin, Eshetu G. Atenafu, Timothy D. Jackson, Allan Okrainec, Fayez A. Quereshy. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumors. Journal of Surgical Oncology 2015; 111(4) doi: 10.1002/jso.23839
|
| 14 |
Xiaonan Yin, Hongxin Yang, Luyao Sun, Yuan Yin, Bo Zhang. Case Report: A liver metastasis 24 years after resection of a very low-risk jejunal gastrointestinal stromal tumor. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1773728
|
| 15 |
Jason S Gold, Mithat Gönen, Antonio Gutiérrez, Javier Martín Broto, Xavier García-del-Muro, Thomas C Smyrk, Robert G Maki, Samuel Singer, Murray F Brennan, Cristina R Antonescu, John H Donohue, Ronald P DeMatteo. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. The Lancet Oncology 2009; 10(11) doi: 10.1016/S1470-2045(09)70242-6
|
| 16 |
Patrick Schöffski, Jean-Yves Blay, Isabelle Ray-Coquard. Cabozantinib as an emerging treatment for sarcoma. Current Opinion in Oncology 2020; 32(4) doi: 10.1097/CCO.0000000000000644
|